bioRxiv · 10.1101/2023.12.21.572728
The dCMP deaminase DCTD and the E3 ligase TOPORS are central mediators of decitabine cytotoxicity
Abstract
The nucleoside decitabine (5-aza-dC) is used to treat several hematological cancers. Upon triphosphorylation and incorporation into DNA, 5-aza-dC induces covalent DNMT1 DNA-protein crosslinks (DPCs) and DNA hypomethylation. However, 5-aza-dC treatment success varies, and relapse is common. Using genome-scale CRISPR/Cas9 screens, we map factors determining 5-aza-dC susceptibility. Unexpectedly, we find that loss of the dCMP deaminase DCTD causes 5-aza-dC resistance, suggesting that 5-aza-dUMP generation underlies most 5-aza-dC cytotoxicity in wild-type cells. Combining results from a subsequent genetic screen in DCTD-deficient cells with identification of the proximal proteome of DNMT1-DPCs, we uncover the ubiquitin/SUMO1 E3 ligase, TOPORS, as a new DPC repair factor. TOPORS is recruited to DNMT1-DPCs in a SUMO-dependent manner and promotes their degradation. Our study suggests that 5-aza-dC-induced DPCs cause cytotoxicity when DPC repair is compromised, while cytotoxicity in wild-type cells arises from perturbed nucleotide metabolism and lays the foundations for the development of predictive biomarkers for decitabine treatment.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Carnie, C. J., Gotz, M. J., Palma-Chaundler, C. S., Weickert, P., Wanders, A. R., Serrano-Benitez, A., Li, H.-Y., Gupta, V., Blum, C. J., Sczaniecka-Clift, M., Zagnoli-Vieira, G., D'Alessandro, G., Richards, S. L., Gueorguieva, N., Beli, P., Stingele, J., Jackson, S. P.. 2023-12-21. The dCMP deaminase DCTD and the E3 ligase TOPORS are central mediators of decitabine cytotoxicity. https://doi.org/10.1101/2023.12.21.572728
Cite the original work for its findings. Save a collection to share your selection of sources.